Venture capital firm

Global Life Science Ventures

Former life sciences venture capital fund in Germany and Switzerland, now in liquidation

Germany
Collaboration
Management
Science
+7 more

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Global Life Science Ventures, known as GLSV, was an independent venture capital fund investing only in the life sciences. It backed early-stage groups from universities, scientific institutions and industry, and some later-stage companies including buy-outs. The fund is now in liquidation and is not seeking new investments.

Products and services

Finance: early-stage funding for life science companies.
Advice and expertise: guidance and access to networks.
Later-stage deals: selected investments, including buy-outs.

Clients

The first fund began in 1996 and invested in 18 companies. The second fund started in 2001, also invested in 18 companies, mainly in Europe and the US, and exited its last assets in 2015. GLSV led the Series A round of GlycArt in 2003 and was involved in its later sale to Roche.

Key facts

Offices: Germany and Switzerland
Status: in liquidation
Focus: life sciences only

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Rankings

Global Life Science Ventures is ranked on 2 TrustList rankings: #16 on 1 and #38 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Global Life Science Ventures has no reviews yet and 2 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 2 rankings

#16of 17
Germany
It is the only one of the 17 here listing biotech and healthtech.
Its profile: “- Offices: Germany and Switzerland - Status: in liquidation - Focus: life sciences only Global Life Science Ventures, known as GLSV, was an independent venture capital fund investing only in the life sciences.”
Of the 17 here, 5 also cover early stage and 5 also cover eCommerce; 5 also work in London and 4 also work in Berlin.
Behind NEDGEX, ahead of Momeni Digital Ventures.
#38of 79
Biotech investors
It is one of 5 here listing collaboration and one of 6 here listing early stage.
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.
Behind Epidarex Capital, ahead of Golden Ventures.

As of 2026-10-30. Organic ranks only; sponsored placements are never ranks. How TrustList ranks

Ask TrustList to introduce you to Global Life Science Ventures

Reviews

Write the first review of Global Life Science Ventures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Global Life Science Ventures.